In RCC, PTEN depletion, PI3KCA mutation, and receptor tyrosine kinases (RTKs) overactivation will result in sustained activation of phosphoinositide 3-kinase (PI3K)-AKT- mammalian target of rapamycin (mTOR) cascade [6–9]. This evidence concerns the gene MTOR and renal cell carcinoma.